Masayuki Hiraki

MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer

Takahiro Maeda, Masayuki Hiraki, Caining Jin et al. · Cancer Research · 2017 · 274 citations · Full text

Medicine, Cancer Biology, Oncology +17

Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells

Masanori Hasegawa, Hidekazu Takahashi, Hasan Rajabi et al. · Oncotarget · 2016 · 199 citations · Full text

Medicine, Cell Biology, Oncology +12

Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression

Kazumasa Komura, Seong Ho Jeong, Kunihiko Hinohara et al. · Proceedings of the National Academy of Sciences · 2016 · 166 citations · Full text

Medicine, Oncology, Pharmacology +17

MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer

Audrey Bouillez, Hasan Rajabi, C Jin et al. · Oncogene · 2017 · 121 citations · Full text

Medicine, Immunology, Oncology +16

Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer

Masayuki Hiraki, Junichi Nishimura, Hidekazu Takahashi et al. · Molecular Therapy — Nucleic Acids · 2015 · 95 citations · Full text

Medicine, Molecular Biology, Oncology +17